Celonib 400 mg Tablet

Celonib 400 mg Tablet is a medication primarily used in the treatment of certain types of cancer, particularly chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST). The active ingredient in Celonib is Imatinib, which belongs to a class of drugs known as tyrosine kinase inhibitors. It works by blocking the action of the abnormal protein that signals cancer cells to multiply, thus slowing or stopping the spread of cancer cells in the body.

This medication is usually prescribed by an oncologist and is to be taken orally with a full glass of water, preferably with a meal to reduce the risk of stomach upset. Dosage and duration of treatment depend on the type and stage of cancer being treated, as well as the patient’s overall health condition.

Key Benefits:

1. Effective in Treating Leukemia: Celonib 400 mg is highly effective in managing and treating chronic myeloid leukemia (CML) by targeting the BCR-ABL tyrosine kinase enzyme that causes the growth of cancer cells.
2. Reduces Tumor Growth: It is used in treating gastrointestinal stromal tumors (GIST) by inhibiting the growth of cancer cells, thus preventing the tumor from growing or spreading to other parts of the body.
3. Targeted Therapy: Unlike traditional chemotherapy, which affects both cancerous and healthy cells, Celonib specifically targets the abnormal proteins in cancer cells, leading to fewer side effects and better treatment outcomes.
4. Improves Survival Rates: Clinical studies have shown that patients with CML and GIST who are treated with Imatinib have significantly improved survival rates compared to those receiving other treatments.
5. Convenient Dosage: The oral administration of Celonib allows for easy and convenient dosing, improving patient adherence to the treatment regimen.
6. Minimal Side Effects: Celonib is generally well-tolerated by most patients, with common side effects including nausea, fatigue, and muscle cramps, which are usually manageable and often decrease over time.